AVXL | Anavex Life Sciences Corp
Category: Consumer goods
Quick infos Headquarters: New York City, New York, United States Trade prices Volume: Market Cap: 1.32B Prev closed: 20.99 Open: 19.91 High: 20.32 Low: 16.95 52 week low: 3.61 52 week high: 28.7 Dividends: Next ER: August 12, 2021 After Market Closes
Earnings History Date EPS / Forecast Revenue / Forecast December 13, 2021 August 12, 2021 -0.14 / -0.134- / -May 13, 2021 -0.12 / -0.13- / -February 11, 2021 -0.12 / -0.105- / -December 28, 2020 -0.1 / -0.1275- / -view more
Historical Data Date Price Open High Low Vol Change ER Oct 8, 2021 17.22 17.44 17.76
17.15
412.90K -1.15% Oct 7, 2021 17.42 17.27 17.72
16.69
613.38K 2.89% Oct 6, 2021 16.93 17.42 17.76
16.82
660.43K -3.97% Oct 5, 2021 17.63 17.33 17.92
17.24
541.55K 1.91% Oct 4, 2021 17.30 17.72 17.78
17.06
549.70K -3.62% Oct 1, 2021 17.95 18.36 18.36
17.22
886.45K 0% Sep 30, 2021 17.95 17.82 18.26
17.42
1.51M 0.73% Sep 29, 2021 17.82 18.45 18.67
17.67
717.71K -3.2% Sep 28, 2021 18.41 18.66 18.82
18.33
723.24K -4.26% Sep 27, 2021 19.23 18.62 19.81
18.51
803.51K 2.61% view more
NASDAQ - Nasdaq Stock Market
News
Anavex Life Sciences EPS in-line seekingalpha.com Aug 12, 2021 7:30 pm Cassava Sciences drags rivals lower amid concerns over its Alzheimer’s drug seekingalpha.com Jul 30, 2021 9:03 pm Anavex Life Sciences rises on positive data for Alzheimer’s therapy in mouse study seekingalpha.com Jul 29, 2021 7:46 pm Is Anavex Life Sciences Corp. (NASDAQ:AVXL) Expensive At $6.39? Here's How To Know. marketingsentinel.com Dec 19, 2020 1:15 pm Alzheimer's drug players shake off concerns from Biogen aducanunab probe seekingalpha.com Jul 12, 2021 10:20 pm Biogen to come under federal probe; pressures other developers in Alzheimer’s space seekingalpha.com Jul 10, 2021 2:07 am Pharmas, payers to meet at Duke to hash out how to pay for Alzheimer's drugs - Endpoints seekingalpha.com Jul 4, 2021 10:00 pm Anavex posts the sharpest one-day loss in over seven months seekingalpha.com Jun 30, 2021 4:49 am Intellia Therapeutics, Verve Therapeutics leads healthcare gainers; CEL-SCI, Acurx Pharmaceuticals among major losers seekingalpha.com Jun 28, 2021 11:04 pm Anavex Life stock soars 16% after ANAVEX2-73 improved endpoints in Phase 2 Parkinson’s disease study seekingalpha.com Jun 28, 2021 7:29 pm Anavex Life under pressure on launch of $50M direct offering seekingalpha.com Jun 22, 2021 7:40 pm Virpax Pharmaceuticals, Anavex Life Sciences leads healthcare gainers; Aptevo Therapeutics, Intec Pharma among major losers seekingalpha.com Jun 21, 2021 11:02 pm Anavex Life shares gain 8% as ANAVEX2-73 shows correlation with efficacy endpoints in mid-stage rett syndrome study seekingalpha.com Jun 21, 2021 8:15 pm Clearside Biomedical, Eloxx Pharmaceuticals leads healthcare gainers; PDS Biotechnology, Sage Therapeutics among major losers seekingalpha.com Jun 15, 2021 11:02 pm Enochian Biosciences, RAPT Therapeutics leads healthcare gainers; Avenue Therapeutics, Inhibikase Therapeutics among major losers seekingalpha.com Jun 14, 2021 11:00 pm Anavex Life outlines mechanism of ANAVEX2-73 and ANAVEX3-71 in treatment of Alzheimer's Disease seekingalpha.com Jun 14, 2021 8:41 pm The road -- and obstacles -- ahead for Biogen's Aduhelm seekingalpha.com Jun 13, 2021 4:00 am Biogen, Eisai and other Alzheimer's players cool off in afternoon trading seekingalpha.com Jun 9, 2021 12:09 am Anavex Life's late-stage ANAVEX2-73 study in Alzheimer’s exceeds target enrollment seekingalpha.com Jun 8, 2021 7:37 pm Biogen Alzheimer's drug Aduhelm (aducanumab) wins FDA approval (updated) seekingalpha.com Jun 7, 2021 11:02 pm Talk about Anavex Life Sciences Corp below in comments section below. Do you think you'll buy? Do you already have active trades now?
EarningsAhead is not affiliated with and this is not an endorsement of the companies featured above.
Share it with fellow traders:
or join discussions in FB below
(
FB comments )
If you are looking for News & events, Press Release, they are available on their Investors Relations site.
If you want to help pay for server cost or for improving this tool. You can send it via Paypal .
Buy on Amazon In the world of investing, slow and steady wins the race. With this mantra in mind, trusted author and finance guru Eric Tyson is back with the latest edition of the #1 bestselling book, Investing For Dummies, to help you achieve your investment goals.
